For pharmaceutical and life sciences manufacturers, batch records must show more than the final production result. They must establish who performed an action, when it happened, what changed, and whether the record remained trustworthy.
Paper records can support regulated operations, but electronic systems introduce specific controls under FDA 21 CFR Part 11 when electronic records replace required paper records. AVEVA Batch Management provides functions designed to support electronic batch records, electronic signatures, role-based security, and traceability.
What Is FDA 21 CFR Part 11?
FDA 21 CFR Part 11 establishes criteria for electronic records and electronic signatures when they are used in FDA-regulated activities. The controls address areas such as system access, electronic signatures, audit trails, record integrity, and validation.
For batch manufacturing, the practical question is simple:
Can your electronic batch record prove what happened, who performed it, when it happened, and whether the record was changed?
AVEVA Batch Management provides features that can support these requirements when properly configured and validated.
Electronic Signatures: Can You Prove Who Approved the Batch?
Electronic signatures must be linked to the person using them and associated with the relevant electronic record. FDA requirements cover signature manifestation, linking, and controls around electronic signatures.
A handwritten signature on a scanned document does not automatically create a compliant electronic-signature process.
AVEVA Batch Management supports electronic “done by” and “check by” signatures within batch execution. These controls can establish operator and reviewer actions within an electronic batch record.
For example:
- Operator executes the batch step.
- System records the action.
- Authorized reviewer checks the action.
- Electronic signature links the approval to the record.
This creates a clearer chain of responsibility than a paper sheet passed between departments.
Audit Trails: Can an Inspector Ask “Who Changed This?”
An audit trail records changes and actions associated with electronic records. FDA describes a compliant audit trail as a secure, computer-generated, time-stamped record that helps reconstruct events involving creation, modification, or deletion of electronic records.
Paper records can show an original entry and later correction. However, they do not automatically provide the same system-generated event history.
An electronic batch system can record information such as:
| Audit information | Why it matters |
|---|---|
| User identity | Shows who performed the action |
| Date and time | Establishes when it occurred |
| Action | Shows what happened |
| Previous value | Helps reconstruct changes |
| New value | Shows the updated record |
| Reason or comment | Provides controlled context |
Data Integrity: Can You Show That Records Were Not Tampered With?
FDA expects electronic records to remain trustworthy, reliable, and protected against unauthorized changes. Part 11 includes controls intended to protect electronic records and signatures.
However, one correction matters here: Part 11 should not be reduced to a simple “checksum or hashing” requirement. FDA’s framework covers broader controls around access, audit trails, record protection, signatures, and system validation.
AVEVA implementations can provide controlled electronic records, audit history, security, and electronic signatures. AVEVA Batch Management specifically supports detailed electronic batch records with traceability and role-based security.
Therefore, data integrity comes from the complete system design, not from one security feature.
IQ/OQ/PQ: Does AVEVA Make Validation Automatic?
Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) are commonly used within computer system and equipment validation programs.
However, purchasing AVEVA does not automatically make a customer system IQ/OQ/PQ validated. The installed system still requires validation based on its intended use, configuration, risk, interfaces, procedures, and regulated process.
FDA recommends a documented, risk-based approach to validation and says validation should consider the effect of computerized systems on record accuracy, reliability, integrity, availability, and authenticity.
AVEVA does provide product documentation and compliance capabilities that can reduce the amount of custom functionality needed for a Part 11-oriented implementation. AVEVA states that its operations control software has full compliance with 21 CFR Part 11.
The remaining work belongs to the manufacturer and its validation team.
Role-Based Security: Can QA Approve What Operators Enter?
A regulated batch system should separate responsibilities where required by the process.
For example:
- Operator: Executes assigned production steps.
- Supervisor: Reviews defined production actions.
- Quality Assurance: Reviews or approves controlled records.
- Administrator: Manages system configuration and user permissions.
AVEVA Batch Management provides built-in role-based security and electronic “done by/check by” signatures for electronic batch records.
FDA guidance also calls for controls that limit system access to authorized individuals and include authority checks.
This makes role design part of the compliance architecture, rather than an afterthought.
Paper Records vs Electronic Batch Records
| Area | Paper batch record | AVEVA electronic batch record |
|---|---|---|
| User identification | Manual | Controlled user identity |
| Timestamp | Handwritten | System-generated |
| Approval | Handwritten signature | Electronic signature |
| Change history | Manual correction | Electronic audit history |
| Role control | Procedural | Role-based security |
| Batch data capture | Manual | Automated capture |
| Record retrieval | Physical search | Electronic retrieval |
| Traceability | Depends on documentation | Linked digital records |
What Engineers Get Wrong About Part 11
The common mistake is treating Part 11 as a software checkbox.
Installing AVEVA is only one part of the project. A compliant implementation also needs:
- Defined intended use.
- User and role design.
- Electronic signature procedures.
- Audit-trail configuration.
- Data and record-retention controls.
- Validation documentation.
- Change-control procedures.
- Periodic review and access management.
In practice, the software, automation system, procedures, users, and validation records must work together.
Why Work With Pima Controls for AVEVA Projects?
Pima Controls helps manufacturers integrate industrial automation and AVEVA software into production environments. For regulated batch operations, the project must connect process control, batch execution, historical records, user permissions, and reporting.
Pima Controls can help define the automation architecture, configure the required AVEVA environment, and plan the implementation around the plant’s validation and documentation needs.
For pharmaceutical and life sciences manufacturers, this approach is more practical than adding compliance features after the automation system has already been built.
Conclusion
FDA 21 CFR Part 11 is not simply about replacing paper with software. It is about controlling electronic records and signatures so that regulated data remains trustworthy, traceable, and attributable.
AVEVA Batch Management provides electronic batch records, role-based security, electronic signatures, and batch data capture that can support a properly validated Part 11 implementation.
If your pharmaceutical plant still relies heavily on paper batch records or a custom electronic system, Pima Controls can assess the existing architecture and define an AVEVA-based path toward controlled electronic batch records.
